Trends in Receipt of Adjuvant Chemotherapy and Impact on Survival in Resected Biliary Tract Cancers

被引:0
|
作者
Rhodin, Kristen E. [1 ]
Liu, Annie [1 ]
Bartholomew, Alex [1 ]
Kramer, Ryan [2 ]
Parameswaran, Anika [1 ]
Uronis, Hope [3 ,4 ]
Strickler, John [3 ,4 ]
Hsu, David [3 ,4 ]
Morse, Michael A. [3 ,4 ]
Shah, Kevin N. N. [1 ]
Herbert, Garth [1 ]
Zani, Sabino [1 ,4 ]
Nussbaum, Daniel P. [1 ,4 ]
Allen, Peter J. [1 ,4 ]
Lidsky, Michael E. [1 ,4 ]
机构
[1] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27707 USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] Duke Univ, Dept Med, Div Med Oncol, Med Ctr, Durham, NC USA
[4] Duke Canc Inst, Durham, NC USA
基金
美国国家卫生研究院;
关键词
D O I
10.1245/s10434-023-13637-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4824 / 4825
页数:2
相关论文
共 50 条
  • [1] Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers
    Rhodin, Kristen E.
    Liu, Annie
    Bartholomew, Alex
    Kramer, Ryan
    Parameswaran, Anika
    Uronis, Hope
    Strickler, John
    Hsu, David
    Morse, Michael A.
    Shah, Kevin N.
    Herbert, Garth
    Zani, Sabino
    Nussbaum, Daniel P.
    Allen, Peter J.
    Lidsky, Michael E.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (8) : 4813 - 4821
  • [2] Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers
    Kristen E. Rhodin
    Annie Liu
    Alex Bartholomew
    Ryan Kramer
    Anika Parameswaran
    Hope Uronis
    John Strickler
    David Hsu
    Michael A. Morse
    Kevin N. Shah
    Garth Herbert
    Sabino Zani
    Daniel P. Nussbaum
    Peter J. Allen
    Michael E. Lidsky
    Annals of Surgical Oncology, 2023, 30 : 4813 - 4821
  • [3] ASO Visual Abstract: Trends in Receipt of Adjuvant Chemotherapy and Impact on Survival in Resected Biliary Tract Cancers
    Kristen E. Rhodin
    Annie Liu
    Alex Bartholomew
    Ryan Kramer
    Anika Parameswaran
    Hope Uronis
    John Strickler
    David Hsu
    Michael A. Morse
    Kevin N. Shah
    Garth Herbert
    Sabino Zani
    Daniel P. Nussbaum
    Peter J. Allen
    Michael E. Lidsky
    Annals of Surgical Oncology, 2023, 30 : 4824 - 4825
  • [4] Adjuvant Chemotherapy in Resected Biliary Tract Cancer
    Primrose, John N.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (07) : 2127 - 2129
  • [5] Adjuvant Chemotherapy in Resected Biliary Tract Cancer
    John N. Primrose
    Annals of Surgical Oncology, 2020, 27 : 2127 - 2129
  • [6] Fluoropyrimidine-based adjuvant chemotherapy in patients with resected biliary tract cancers.
    Go, Se-il
    Kang, Jung Hun
    Jeong, Chi-Young
    Lee, Gyeong-won
    Kim, Hoon-Gu
    Kang, Myoung-Hee
    Song, Haa-na
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis
    Ghidini, Michele
    Tomasello, Gianluca
    Botticelli, Andrea
    Barni, Sandro
    Zabbialini, Giampietro
    Seghezzi, Silvia
    Passalacqua, Rodolfo
    Braconi, Chiara
    Petrelli, Fausto
    HPB, 2017, 19 (09) : 741 - 748
  • [8] Meta-analysis of randomized clinical trials of adjuvant chemotherapy for resected biliary tract cancers
    Ma, Wen-Jie
    Jin, Yan-Wen
    Wu, Zhen-Ru
    Yang, Qin
    Wang, Jun-Ke
    Liu, Fei
    Shi, Yu-Jun
    Li, Quan-Sheng
    Cheng, Nan-Sheng
    HPB, 2020, 22 (07) : 939 - 949
  • [9] ADJUVANT CHEMOTHERAPY FOR RESECTED BILIARY TRACT CANCER: A RETROSPECTIVE ANALYSIS
    Caponi, S.
    Lucchesi, M.
    Vasile, E.
    Caparello, C.
    Ginocchi, L.
    Lencioni, M.
    Ricci, S.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 262 - 262
  • [10] Neoadjuvant and Adjuvant Therapy Does Not Improve Survival in Resected Biliary Cancers
    Glazer, E. S.
    Ellis, V. G.
    Abdalla, E. K.
    Vauthey, J. N.
    Curley, S. A.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S89 - S89